Focused on discovering and developing next-generation medicines for neurodegenerative diseases.
Location: United States, Illinois, Chicago
Total raised: $85M
Investors 4
| Date | Name | Website |
| 15.01.2022 | Omega Fund... | omegafunds... |
| - | Avoro Capi... | avorocapit... |
| - | OrbiMed | orbimed.co... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.09.2021 | Series B | $85M | Omega Fund... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 13.03.2024 | Vanqua Bio to Present at the Stifel 2024 CNS Days Conference | - | globenewsw... |
| 24.03.2022 | Vanqua Bio to Present at the Stifel 2022 CNS Day Conference | CHICAGO, March 24, 2022 (GLOBE NEWSWIRE) -- Vanqua Bio today announced that the company will partici... | globenewsw... |
| 14.09.2021 | Vanqua Bio snags $85M series B to vanquish Parkinson's, Gauc... | As its name suggests, Vanqua Bio wants to vanquish neurodegenerative diseases like Parkinson's and A... | fiercebiot... |
| 14.09.2021 | Vanqua Bio Launches with $85 Million Series B Financing and ... | – Novel drug-development approach combines advanced insights into critical neuronal cell pathways wi... | marketscre... |
| - | Neuro startup Vanqua Bio emerges with $85M and a first focus... | Vanqua Bio, a biotech startup developing new treatments for neurodegenerative disorders, has launche... | medcitynew... |